SCHEMBL24107293

SCHEMBL24107293

COc1nc(C(C)C)ccc1N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.34
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
EP300 Q09472 1/20 0.33
KAT8 Q9H7Z6 1/20 0.33
MAPT P10636 1/20 0.33
CASP1 P29466 1/20 0.33
ALDH1A1 P00352 5/20 0.32
CYP3A4 P08684 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2B6 P20813 1/20 0.32
FLT3 P36888 1/20 0.32
KCNH2 Q12809 1/20 0.32
HASPIN Q8TF76 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30271332 0.82 MAPT (0.32) MAPTCASP1ALDH1A1CYP3A4TDP1
SCHEMBL15431048 0.80 HTR1B (0.33) ALDH1A1CYP2C19PDCD1LG2CD274CYP1A2
SCHEMBL8738104 0.78 NOS3 (0.31) NOS3NOS1NOS2ALDH1A1CYP2C19
SCHEMBL21238615 0.78 SLC10A2 (0.37) IDO1MAPTALDH1A1TDP1
SCHEMBL8738081 0.78 PDCD1LG2 (0.37) ALDH1A1CYP2C19CYP2C8CYP2C9CYP2B6
SCHEMBL16434743 0.76 GRM4 (0.38) MAPTALDH1A1CYP3A4TSHRHSD17B10
SCHEMBL29948393 0.75 IDO1 (0.36) IDO1EP300KAT8MAPTCASP1
SCHEMBL156162 0.75 IDO1 (0.36) IDO1EP300KAT8MAPTCASP1
SCHEMBL12776063 0.74 NOS3 (0.39) NOS3NOS1NOS2ALDH1A1AURKA
SCHEMBL13746013 0.74 NCF1 (0.42) IDO1NOS3NOS1NOS2EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387941-A1 Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof SHANGHAI MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387941-A1 Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof CD274, PDCD1LG2, PDCD1 IDO1 10/4885NOS3 2507/4885NOS1 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.